Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women
- 4 August 1990
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 336 (8710), 265-269
- https://doi.org/10.1016/0140-6736(90)91801-g
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Transdermal administration of oestrogen/progestagen hormone replacement therapyThe Lancet, 1990
- The effect of age and menopause on bone mineral density of the proximal femurJournal of Bone and Mineral Research, 1989
- Determinants of bone density in normal women: risk factors for future osteoporosis?BMJ, 1989
- Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: a double blind placebo controlled studyBMJ, 1988
- Regional and total skeletal measurements in the early postmenopause.JCI Insight, 1987
- The effect of percutaneous estradiol and natural progesterone on postmenopausal bone lossAmerican Journal of Obstetrics and Gynecology, 1987
- Postmenopausal osteoporosis.BMJ, 1982
- Measurement of the fasting urinary hydroxyproline: creatinine ratio in normal adults and its variation with age and sex.Journal of Clinical Pathology, 1982
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN: EVIDENCE FOR AN INCREASED BONE MASS AFTER DELAYED ONSET OF ŒSTROGEN TREATMENTThe Lancet, 1976